Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
NCT01854034Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Luminespib in non-small cell lung cancer (NSCLC), sponsored by Massachusetts General Hospital. Started Jul 2013; status: completed.
02
Drugs
Luminespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01854034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854034.